Stocks · Korea
059210
KOSDAQ
Metabiomed
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER8.54x
PBR0.81x
EPS438 KRW
BPS4,594 KRW
ROE7.44%
Dividend yield2.81%
DPS105 KRW
Payout ratio23.97%
Returns and 52-week range
1W+2.46%
1M-3.10%
3M+1.08%
6M-13.68%
1Y-39.44%
YTD-24.82%
52W high6,520원
52W low3,265원
From 52W high-42.41%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 689억 | 53억 | 36억 | 7.7% |
| 2023 | 831억 | 107억 | 98억 | 12.9% |
| 2024 | 940억 | 172억 | 223억 | 18.3% |
| 2025 | 1,030억 | 214억 | 108억 | 20.8% |
| Quarterly | ||||
| 2024 4Q | 231억 | 48억 | 90억 | 21.0% |
| 2025 1Q | 277억 | 56억 | 56억 | 20.3% |
| 2025 2Q | 255억 | 78억 | -9억 | 30.6% |
| 2025 3Q | 235억 | 51억 | 45억 | 21.6% |
| 2025 4Q | 262억 | 29억 | 16억 | 11.2% |
| 2026 1Q | 244억 | 49억 | 44억 | 19.9% |
Company
Address: 충청북도 청주시 흥덕구 오송읍 오송생명1로 270
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-29[기재정정]사업보고서 (2025.12)
- 2026-05-15[기재정정]분기보고서 (2026.03)
- 2026-05-15분기보고서 (2026.03)
- 2026-05-14[기재정정]주요사항보고서(자기주식취득결정) Major
- 2026-05-14주요사항보고서(자기주식취득결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.